176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.86%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-11.74%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-24.42%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-24.42%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-22.60%
Negative net income growth while INTC stands at 748.33%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-26.67%
Negative EPS growth while INTC is at 733.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-20.00%
Negative diluted EPS growth while INTC is at 720.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
7.05%
Slight or no buybacks while INTC is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-2.88%
Reduced diluted shares while INTC is at 2.28%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.79%
Dividend growth under 50% of INTC's 9.76%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-60.89%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-65.97%
Negative FCF growth while INTC is at 6.37%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
109.76%
Similar 10Y revenue/share CAGR to INTC's 105.64%. Walter Schloss might see both firms benefiting from the same long-term demand.
117.85%
5Y revenue/share CAGR above 1.5x INTC's 35.20%. David Dodd would look for consistent product or market expansions fueling outperformance.
65.88%
3Y revenue/share CAGR above 1.5x INTC's 27.50%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-15.88%
Negative 10Y OCF/share CAGR while INTC stands at 251.26%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
3285.57%
5Y OCF/share CAGR above 1.5x INTC's 55.25%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
76.35%
3Y OCF/share CAGR above 1.5x INTC's 44.37%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
250.47%
Net income/share CAGR at 75-90% of INTC's 282.16%. Bill Ackman would press for strategic moves to boost long-term earnings.
772.59%
5Y net income/share CAGR above 1.5x INTC's 130.57%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
250.74%
3Y net income/share CAGR above 1.5x INTC's 126.80%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
167.49%
10Y equity/share CAGR 1.25-1.5x INTC's 113.66%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
48.77%
5Y equity/share CAGR is in line with INTC's 45.09%. Walter Schloss would see parallel mid-term profitability and retention policies.
38.98%
3Y equity/share CAGR 1.25-1.5x INTC's 29.58%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.72%
3Y dividend/share CAGR above 1.5x INTC's 24.90%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
18.16%
Our AR growth while INTC is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
3.40%
Inventory growth well above INTC's 2.33%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.38%
Negative asset growth while INTC invests at 4.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.59%
We have a declining book value while INTC shows 1.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-21.52%
We’re deleveraging while INTC stands at 6.71%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
4.31%
R&D growth drastically higher vs. INTC's 1.13%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
5.11%
SG&A growth well above INTC's 2.70%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.